Genpharmasec Limited reported earnings results for the first quarter ended June 30, 2022. For the first quarter, the company reported sales was INR 68.76 million compared to INR 81.03 million a year ago. Revenue was INR 69 million compared to INR 81.62 million a year ago. Net loss was INR 2.14 million compared to net income of INR 1.45 million a year ago. Basic loss per share from continuing operations was INR 0.01 compared to basic earnings per share from continuing operations of INR 0.01 a year ago. Diluted loss per share from continuing operations was INR 0.01 compared to diluted earnings per share from continuing operations of INR 0.01 a year ago.